- Home
- CLGN vs NMTC Comparison
CLGN vs NMTC Comparison
Compare CLGN & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- NMTC
- Stock Information
- Founded
- CLGN 2004
- NMTC 2009
- Country
- CLGN Israel
- NMTC United States
- Employees
- CLGN N/A
- NMTC N/A
- Industry
- CLGN Industrial Specialties
- NMTC Medical/Dental Instruments
- Sector
- CLGN Health Care
- NMTC Health Care
- Exchange
- CLGN Nasdaq
- NMTC Nasdaq
- Market Cap
- CLGN 22.1M
- NMTC 30.9M
- IPO Year
- CLGN N/A
- NMTC N/A
- Fundamental
- Price
- CLGN $3.18
- NMTC $0.61
- Analyst Decision
- CLGN Strong Buy
- NMTC Strong Buy
- Analyst Count
- CLGN 2
- NMTC 1
- Target Price
- CLGN $11.50
- NMTC $1.45
- AVG Volume (30 Days)
- CLGN 165.3K
- NMTC 269.2K
- Earning Date
- CLGN 05-28-2025
- NMTC 05-13-2025
- Dividend Yield
- CLGN N/A
- NMTC N/A
- EPS Growth
- CLGN N/A
- NMTC N/A
- EPS
- CLGN N/A
- NMTC N/A
- Revenue
- CLGN $2,472,000.00
- NMTC $5,758,777.00
- Revenue This Year
- CLGN $2,177.67
- NMTC $292.88
- Revenue Next Year
- CLGN $56.52
- NMTC N/A
- P/E Ratio
- CLGN N/A
- NMTC N/A
- Revenue Growth
- CLGN N/A
- NMTC 54.53
- 52 Week Low
- CLGN $1.55
- NMTC $0.40
- 52 Week High
- CLGN $5.63
- NMTC $1.39
- Technical
- Relative Strength Index (RSI)
- CLGN 59.91
- NMTC 44.39
- Support Level
- CLGN $1.90
- NMTC $0.59
- Resistance Level
- CLGN $4.98
- NMTC $0.66
- Average True Range (ATR)
- CLGN 0.40
- NMTC 0.05
- MACD
- CLGN 0.25
- NMTC 0.00
- Stochastic Oscillator
- CLGN 47.52
- NMTC 22.66
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.